Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Neuraxis Q2 EPS $(1.21) Down From $(0.87) YoY, Sales $646.00K Down From $682.60K YoY

Author: Benzinga Newsdesk | September 21, 2023 08:13am

Neuraxis (AMEX:NRXS) reported quarterly losses of $(1.21) per share. This is a 39.08 percent decrease over losses of $(0.87) per share from the same period last year. The company reported $646.00 thousand in sales this quarter. This is a 5.36 percent decrease over sales of $682.60 thousand the same period last year.

Posted In: NRXS


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist